Literature DB >> 27923699

In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.

Mansa Fredua-Agyeman1, Paul Stapleton2, Abdul W Basit3, Anthony E Beezer4, Simon Gaisford5.   

Abstract

The aim of the study was to investigate the influence of some commercial probiotics on the growth of Clostridium difficile using isothermal microcalorimetry, a technique which can monitor the real time growth of bacteria. Commercial probiotic strains and products, Lactobacillus acidophilus LA-5®, Bifidobacterium lactis BB-12®, Probio 7® and Symprove™ were co-cultured with C. difficile in Brain Heart Infusion (BHI) broth supplemented with 0.1% (w/v) l-cysteine hydrochloride and 0.1% (w/v) sodium taurocholate and monitored in the microcalorimeter. Pseudomonas aeruginosa NCIMB 8628 was also co-cultured with C. difficile and studied. The results indicated inhibition of C. difficile by the probiotics. The inhibition of C. difficile was shown to be pH-dependent using neutralized and unmodified cell free supernatant (CFS) produced by the probiotic strains. However, concentrated CFS of the probiotics also inhibited the intestinal pathogen in a non pH-dependent manner, likely due to specific antimicrobial substances produced. The results also indicated that C. difficile growth was greatly influenced by the presence of sodium taurocholate and by the pH of the medium. A medium pH of between 6.45 and 6.9 demonstrated maximum growth of the organism in the microcalorimeter.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Co-culture; Inhibition; Isothermal microcalorimetry; Probiotics

Mesh:

Substances:

Year:  2016        PMID: 27923699     DOI: 10.1016/j.ijpharm.2016.12.005

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  The Impact of pH on Clostridioides difficile Sporulation and Physiology.

Authors:  Daniela Wetzel; Shonna M McBride
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

2.  The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.

Authors:  Sathursha Gunaratnam; Carine Diarra; Patrick D Paquette; Noam Ship; Mathieu Millette; Monique Lacroix
Journal:  Probiotics Antimicrob Proteins       Date:  2021-01-25       Impact factor: 4.609

3.  Microbiota in vitro modulated with polyphenols shows decreased colonization resistance against Clostridioides difficile but can neutralize cytotoxicity.

Authors:  Aleksander Mahnic; Jennifer M Auchtung; Nataša Poklar Ulrih; Robert A Britton; Maja Rupnik
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

4.  Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease.

Authors:  Jonas Ghyselinck; Lynn Verstrepen; Frédéric Moens; Pieter Van Den Abbeele; Arnout Bruggeman; Jawal Said; Barry Smith; Lynne Ann Barker; Caroline Jordan; Valentina Leta; K Ray Chaudhuri; Abdul W Basit; Simon Gaisford
Journal:  Int J Pharm X       Date:  2021-07-02

Review 5.  Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection.

Authors:  Miguel Tortajada-Girbés; Alejandro Rivas; Manuel Hernández; Ana González; Maria A Ferrús; Maria C Pina-Pérez
Journal:  Foods       Date:  2021-05-19

6.  Screening of Host Specific Lactic Acid Bacteria Active Against Escherichia coli From Massive Sample Pools With a Combination of in vitro and ex vivo Methods.

Authors:  Hao Ren; Eva-Maria Saliu; Jürgen Zentek; Farshad Goodarzi Boroojeni; Wilfried Vahjen
Journal:  Front Microbiol       Date:  2019-11-21       Impact factor: 5.640

Review 7.  What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?

Authors:  Josie M van Dorst; Rachel Y Tam; Chee Y Ooi
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.